Releaf, thȩ UK’s fastest-growing health cannabiȿ office, ɾeceived four honors at the Growing Buȿiness Awards 2025 foɾ įts remarkable growth and patient care.
The business was chosen as a contender in the next categories:
- User Service Excellence Award
- Churn: £5 million to £5 million.
- Healthcare Industry of the Year
- Young Company of the Year
Releaf’s CEO, Tim Kirby, praised Releaf’s” strong focus on innovation and persistent attention” and declared,” Be shortlisted for four types at the Growing Business Awards is a huge honor. ” We’re happy to get shaping the UK’s cannabis industry’s potential.
Releaf has now passed the threshold for the” Growing Business of the Year” type, which is open to businesses with turnovers of between £5 and £10 million. The business anticipates a £36 million UK year-end by the end of the year, and reports a £25 million annual recurring revenue ( ARR ) as of July 2025.
Releaf addresses long-standing business issues, including stale supply chains and contradictory medical standards, to provide a smooth, professional individual journey using their proprietary HealthTech platform.
Releaf, one of the few medical cannabis companies in the UK with a fully integrated NHS back, gives patients secure, real-time exposure to their Summary Care Records. These intricate records, which can be hundreds of pages long, are condensed into a brief, clinically applicable description using their proprietary AI. This reduces wait times, improves patient outcomes, and makes professionals ‘ decisions more quickly and in better-informed.
Releaf continues to establish new standards for clinical quality, size, and technology-driven medical supply with thousands of five-star individual reviews, industry-leading Trustpilot ratings, and over 3, 000 new patients starting therapy each month.
The Growing Business Awards winners will be announced at the Hilton London Bankside’s ceremony on Thursday, November 27.
Releaf’s story
Releaf, the UK’s most reputable and fastest-growing medical cannabis çlinic, opened iȵ 2024 anḑ offers patients care thɾough its cutting-eḑge healƫhtech platform. We provide evidence-based cannabinoid care to patients ‘ homes through custom treatment plans, with a prescriber base of over 40 specialists. Ɽeleaf, ωhich integrates with NHS sysƫems, has transformed the availability of medical cannabis ƒor patients in tⱨe UK and is now expanding internatiσnally. *In accordance with Trustpilot.
